72 related articles for article (PubMed ID: 38553521)
1. Aptamer-based assembly systems for SARS-CoV-2 detection and therapeutics.
Dong Y; Wang J; Chen L; Chen H; Dang S; Li F
Chem Soc Rev; 2024 Jul; 53(13):6830-6859. PubMed ID: 38829187
[TBL] [Abstract][Full Text] [Related]
2. MVsim is a toolset for quantifying and designing multivalent interactions.
Bruncsics B; Errington WJ; Sarkar CA
Nat Commun; 2022 Sep; 13(1):5029. PubMed ID: 36068204
[TBL] [Abstract][Full Text] [Related]
3. Targeting NRP1 axis as a strategy for treating energy metabolism impairment induced by SARS-CoV-2 spike.
Zhang L; Hu W; Li J; Li Y; Liu F; Xiao W; Jiang N; Xiao Z; Han L; Zhou W
Sci China Life Sci; 2024 Jun; ():. PubMed ID: 38902449
[No Abstract] [Full Text] [Related]
4. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents.
Nandi S; Roy H; Gummadi A; Saxena AK
Curr Drug Targets; 2021; 22(17):2006-2020. PubMed ID: 33687893
[TBL] [Abstract][Full Text] [Related]
5. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
[TBL] [Abstract][Full Text] [Related]
6. A new DNA aptamer which binds to SARS-CoV-2 spike protein and reduces pro-inflammatory response.
Kim W; Song ES; Lee SH; Yang SH; Cho J; Kim SJ
Sci Rep; 2024 Mar; 14(1):7516. PubMed ID: 38553521
[TBL] [Abstract][Full Text] [Related]
7. DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach.
Silwal AP; Thennakoon SKS; Arya SP; Postema RM; Jahan R; Phuoc CMT; Tan X
Theranostics; 2022; 12(12):5522-5536. PubMed ID: 35910791
[No Abstract] [Full Text] [Related]
8. DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.
Villa A; Brunialti E; Dellavedova J; Meda C; Rebecchi M; Conti M; Donnici L; De Francesco R; Reggiani A; Lionetti V; Ciana P
Pharmacol Res; 2022 Jan; 175():105982. PubMed ID: 34798263
[TBL] [Abstract][Full Text] [Related]
9. Xeno-Nucleic Acid (XNA) 2'-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor-Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding.
Alves Ferreira-Bravo I; DeStefano JJ
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696413
[TBL] [Abstract][Full Text] [Related]
10. A SARS-CoV-2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD-Independent Mechanism*.
Schmitz A; Weber A; Bayin M; Breuers S; Fieberg V; Famulok M; Mayer G
Angew Chem Int Ed Engl; 2021 Apr; 60(18):10279-10285. PubMed ID: 33683787
[TBL] [Abstract][Full Text] [Related]
11. Structure-Guided Development of Bivalent Aptamers Blocking SARS-CoV-2 Infection.
Rahman MS; Han MJ; Kim SW; Kang SM; Kim BR; Kim H; Lee CJ; Noh JE; Kim H; Lee JO; Jang SK
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375202
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 spike protein promotes inflammatory cytokine activation and aggravates rheumatoid arthritis.
Lee AR; Woo JS; Lee SY; Lee YS; Jung J; Lee CR; Park SH; Cho ML
Cell Commun Signal; 2023 Mar; 21(1):44. PubMed ID: 36864432
[TBL] [Abstract][Full Text] [Related]
13. The Inhibition of SARS-CoV-2 and the Modulation of Inflammatory Responses by the Extract of
Rather IA; Lew LC; Kamli MR; Hakeem KR; Sabir JSM; Park YH; Hor YY
Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560517
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Evaluation of
Alzahrani OR; Hawsawi YM; Alanazi AD; Alatwi HE; Rather IA
Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298446
[TBL] [Abstract][Full Text] [Related]
15. Aptamers for SARS-CoV-2: Isolation, Characterization, and Diagnostic and Therapeutic Developments.
Amini R; Zhang Z; Li J; Gu J; Brennan JD; Li Y
Anal Sens; 2022 Sep; 2(5):e202200012. PubMed ID: 35574520
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
